Suchergebnisse - (Person:"Liu, Geoffrey")

PubPharm (25)

1

Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence

enthalten in: Current oncology (Toronto, Ont.) | 2024

von Moulson, R. | Law, J. | Sacher, A. | +12

2

Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Moghal, N. | Li, Q. | Stewart, E. | +10

CommentIn: J Thorac Oncol. 2023 Apr;18(4):399-401. - PMID 36990572

3

EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Sara Kuruvilla, M. | Liu, G. | Syed, I. | +17

4

Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers : Examples Based on the International Lung Cancer Consortium Data

enthalten in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 2022

von Schmid, S. | Jiang, M. | Brown, M. | +54

5

Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors

enthalten in: Clinical lung cancer | 2021

von Lau, S. | Fares, A. | Le, L. | +12

6

Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib

enthalten in: Clinical lung cancer | 2020

von Schmid, S. | Stewart, E. | Martins-Filho, S. | +15

7

EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2020

von Martins-Filho, S. | Weiss, J. | Pham, N. | +19

8

Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer

enthalten in: Cancer medicine | 2019

von Jiang, S. | Walton, R. | Hueniken, K. | +18

9

The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC : A Real World Evidence Analysis

enthalten in: The oncologist | 2019

von O'Kane, G. | Su, J. | Tse, B. | +19

10

The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von O'Kane, G. | Liu, G. | Stockley, T. | +8